Drug Profile
Research programme: PPAR-gamma agonists - Evolva Biotech
Latest Information Update: 22 Feb 2010
Price :
$50
*
At a glance
- Originator Evolva Biotech
- Class Small molecules
- Mechanism of Action Peroxisome proliferator-activated receptor gamma agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Diabetes mellitus
Most Recent Events
- 07 Mar 2007 Preclinical trials in Diabetes mellitus in Switzerland (unspecified route)